Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of miRNAs in Endometrial Cancer as Novel Diagnostic and Prognostic Biomarkers

NCT04845425 is registered in ClinicalTrials.gov with IRCCS Azienda Ospedaliero-Universitaria di Bologna as lead sponsor.

NCT NCT04845425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04845425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of miRNAs in Endometrial Cancer as Novel Diagnostic and Prognostic Biomarkers
Lead sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2021
Completion date
December 31, 2022
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer